跳至主要内容
临床试验/NCT03193255
NCT03193255已完成不适用

Efficacy and Safety of Povidone Iodine-based Disinfecting Solution (cleadewGP) for Rigid Contact Lenses

The Hong Kong Polytechnic University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Change in corneal staining and injection before and 6 months after ortho-k lens wear

研究概览

简要总结

Multipurpose solutions (MPS) are the most commonly prescribed regimen to clean, disinfect and rinse rigid lenses. The preservatives used in MPS may cause hypersensitivity and the presence of quaternary ammonium compounds (QAC) may increase development of antiseptic resistance mediated by QAC resistance genes, thus lowering the efficacy of disinfection. Povidone-iodine (PVI) has been safely used as a disinfectant for ophthalmic operations and eye drops. The cleadew GP (Ophtecs, Japan) tested in the current study is a PVI based rigid lens disinfecting solutions which does not employ QAC. If its efficacy and safety can be confirmed in this study, it will be a good alternative rigid lens care regimen for children.

详细描述

Multipurpose solutions (MPS) are the most commonly prescribed regimen to clean, disinfect and rinse rigid lenses. These solutions usually contain quaternary ammonium compounds (QAC) which have been shown to be selective for carriage of organisms harbouring QAC genes in orthokeratology (ortho-k) lens wear and it raises concerns about safety with the increasing popularity of orthokeratology (ortho-k) for myopia control in children. Hydrogen peroxide system is a good alternative but this option is limited in rigid lens market. The only brand available in Hong Kong labelled as safe for rigid contact lenses has limited disinfecting power. cleadewGP (Ophtecs, Japan) is a new disinfecting solution for rigid contact lenses which does not employ QAC and instead is povidone iodine (PVI) based. PVI has been safely used as a disinfectant for ophthalmic operations and is commonly used in eye drops. PVI-based soft and rigid lens solutions have been reported to be as effective against Pseudomonas aeruginosa as other MPS and hydrogen peroxide-based solutions. However, other efficacy against other organisms need to be demonstrated to allow this solution to meet FDA requirements. The PVI-based soft lens solution was also reported to be effective against Acanthamoeba. cleadewGP is relatively new in the market and not much work has been done on the efficacy and safety of this solution. If confirmed to be effective and safe, cleadewGP may be a better alternative to ortho-k lens wearers who need to use disinfecting solutions at least for a few years while under ortho-k treatment. In the absence of QAC, there will be no concern of selection of carriage of organisms harbouring QAC genes in ortho-k lens wearers using this disinfecting solution over time.

The current study aims at investigating the effectiveness and safety of the cleadewGP for cleaning (lipid and protein removal) and disinfecting of ortho-k lenses by comparing the outcomes collected from subjects randomly assigned to one of the following study groups.

Group 1: cleadewGP without lens rubbing Group 2: cleadewGP with lens rubbing Group 3: cleadewGP with separate daily cleaner Group 4: cleadewGP with separate daily cleaner and weekly protein removal agent

Four study visits will be involved in this 6 months study: baseline, 1-month, 3-month, and 6-month after lens wear. Complimentary solutions will be provided during the study period. Solutions and accessories will be replaced at monthly interval. Effectiveness for cleaning and disinfection and safety of lens wear will be determined by comparing the changes in ocular microbiome before and after lens wear, contamination levels of lenses and accessories, biomicroscopic examination of lenses and eyes, and subjective rating of lens comfort among the four groups of subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
6 Years 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • cycloplegic objective sphere between -1.00D to -4.00D
  • cycloplegic objective astigmatism ≤ 2.00D
  • anisometropia < 1.00D
  • best-corrected logMAR visual acuity 0.10 or better in both eyes
  • symmetrical corneal topography with toricity ≤ 2.00D
  • normal ocular health

排除标准

  • contraindication to ortho-k wear
  • prior history of myopia control treatment
  • prior history of rigid contact lens wear
  • strabismus or amblyopia
  • systemic or ocular conditions which might affect refractive development
  • poor response or poor compliance to lens wear including poor lens handling, poor vision, and/ocular response after lens modifications

结局指标

主要结局

Change in corneal staining and injection before and 6 months after ortho-k lens wear

时间窗: 6 months

Grading of corneal staining, limbal injection and conjunctival injection under slitlamp biomicroscopy before and after ortho-k lens wear

Change in subjective symptoms before and 6 months after lens wear

时间窗: 6 months

Questionnaire of ocular comfort will be administered to rate symptoms of discomfort, itching, tearing, dryness and redness

次要结局

  • Change in levels of ocular microbiome before and 6 months after ortho-k lens wear(6 months)
  • Levels of contamination of lens cases(6 months)
  • Levels of contamination of lenses(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pauline Cho

Professor

The Hong Kong Polytechnic University

研究点 (1)

Loading locations...

相似试验